These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 3440041)
1. [Concentration-time profile of isosorbide dinitrate and its metabolites in plasma following percutaneous resorption of a transdermal therapeutic system]. Menke G; Schnellhammer R; Rietbrock N Arzneimittelforschung; 1987 Nov; 37(11):1301-3. PubMed ID: 3440041 [TBL] [Abstract][Full Text] [Related]
2. Oral absorption and disposition of isosorbide dinitrate and isosorbide mononitrates in man. Laufen H; Aumann M; Leitold M Arzneimittelforschung; 1983; 33(7):980-4. PubMed ID: 6684933 [TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetics of low-dose isosorbide dinitrate and metabolites after buccal or oral administration]. Keller-Stanislawski B; Marschner JP; Rietbrock N Arzneimittelforschung; 1992 Jan; 42(1):17-20. PubMed ID: 1586374 [TBL] [Abstract][Full Text] [Related]
4. Bioavailability and pharmacokinetics of a new isosorbide dinitrate spray preparation in healthy volunteers. Hutt V; Theodor R; Pabst G; Lutz D; Bonn R; Fritschi E Arzneimittelforschung; 1993 Aug; 43(8):842-6. PubMed ID: 8216439 [TBL] [Abstract][Full Text] [Related]
5. Effect of penetration enhancers on isosorbide dinitrate penetration through rat skin from a transdermal therapeutic system. Gabiga H; Cal K; Janicki S Int J Pharm; 2000 Apr; 199(1):1-6. PubMed ID: 10794921 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of isosorbide dinitrate and isosorbide-5-mononitrate. Schaumann W Int J Clin Pharmacol Ther Toxicol; 1989 Sep; 27(9):445-53. PubMed ID: 2681004 [TBL] [Abstract][Full Text] [Related]
7. Concentrations of isosorbide dinitrate, isosorbide-2-mononitrate and isosorbide-5-mononitrate in human vascular and muscle tissue under steady-state conditions. Schneider W; Menke G; Heidemann R; Satter P; Kaltenbach M; Rietbrock N Eur J Clin Pharmacol; 1990; 38(2):145-7. PubMed ID: 2338111 [TBL] [Abstract][Full Text] [Related]
8. [Bioavailability of isosorbide dinitrate and isosorbide-5-mononitrate under steady-state conditions]. Rietbrock N; Knoll J; Merz PG; Menke G Dtsch Med Wochenschr; 1985 Nov; 110(47):1821-5. PubMed ID: 3905327 [TBL] [Abstract][Full Text] [Related]
9. Bioavailability and metabolism of isosorbide dinitrate from a transdermal spray. Laufen H; Leitold M Arzneimittelforschung; 1992 Jul; 42(7):931-5. PubMed ID: 1418058 [TBL] [Abstract][Full Text] [Related]
10. [Comparative pharmacokinetics and bioavailability of isosorbide dinitrate and its metabolites isosorbide 5- and 2-mononitrate from delayed-release preparations]. Geigenberger A; Degen J; Maier-Lenz H Arzneimittelforschung; 1982; 32(9):1138-40. PubMed ID: 6890839 [TBL] [Abstract][Full Text] [Related]
11. [Plasma levels of isosorbide dinitrate and its metabolites during intravenous infusion in surgical patients--effect of preoperative administration of isosorbide dinitrate]. Murakawa T; Hashimoto Y; Sato T; Takagi H; Kushikata T; Araki I; Kou H; Kimura F; Matsuki A Masui; 1993 Feb; 42(2):225-32. PubMed ID: 8437354 [TBL] [Abstract][Full Text] [Related]
12. [Comparative study of the bioavailability and pharmacokinetics of isosorbide dinitrate formulations in retard form and in standard preparations by determination of isosorbide-5-mononitrate]. Lutz VD; Gielsdorf W; Rasper J; Jaeger H; Loew D Arzneimittelforschung; 1985; 35(4):730-4. PubMed ID: 4015739 [TBL] [Abstract][Full Text] [Related]
13. A simple and sensitive gas chromatography method for determination of isosorbide dinitrate and its metabolites in human plasma: application to pharmacokinetics study on oral spray. Jiang Z; Wei C; Sun Z; Guo J; Li R; Zhang R; Yuan G; Guo R Drug Res (Stuttg); 2014 Feb; 64(2):73-8. PubMed ID: 23904215 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and metabolism of isosorbide-dinitrate after intravenous and oral administration. Abshagen U; Betzien G; Endele R; Kaufmann B; Neugebauer G Eur J Clin Pharmacol; 1985; 27(6):637-44. PubMed ID: 3987768 [TBL] [Abstract][Full Text] [Related]
16. [Bioavailability and bioequivalence of organic nitrates. Isosorbide dinitrate--a study of sustained-release preparations]. Scheidel B; Blume H; Stenzhorn G; Siewert M; Babej-Dölle RM Arzneimittelforschung; 1991 Mar; 41(3):212-8. PubMed ID: 1867657 [TBL] [Abstract][Full Text] [Related]
17. [Hemodynamic effects of a transdermal formulation of isosorbide dinitrate and its pharmacokinetics in conscious dogs]. Kogi K; Tanaka O; Kimura T; Saito T Nihon Yakurigaku Zasshi; 1982 Oct; 80(4):279-88. PubMed ID: 7152395 [TBL] [Abstract][Full Text] [Related]
18. Bioavailability of isosorbide dinitrate and its two mononitrate metabolites from sustained-release formulations. Chasseaud LF; Doyle E; Taylor T; Darragh A; Lambe RF Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):514-8. PubMed ID: 6642789 [TBL] [Abstract][Full Text] [Related]
19. A pharmacokinetic model for isosorbidedinitrate, isosorbide-2-mononitrate, and isosorbide-5-mononitrate. Smith D; Aldrich W; Dey M; Enever R; Warner R; Weierstall R Drug Metab Dispos; 1990; 18(4):429-34. PubMed ID: 1976063 [TBL] [Abstract][Full Text] [Related]
20. [Dose-dependent serum concentration of ISDN and its metabolites following administration of ISDN-retard. Studies under steady-state conditions]. Loew D; Deuster U; Burkhardt H; Rietbrock N Dtsch Med Wochenschr; 1986 Nov; 111(48):1834-7. PubMed ID: 3536397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]